相关实验视频

Updated: Jul 9, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

对于恶性瘤的采用细胞免疫疗法的现状和前景

Dong Zhao¹, Dantong Zhu¹, Fei Cai¹

¹Department of Oncology, General Hospital of Northern Theater Command, Shenyang, P. R. China.

Technology in cancer research & treatment

|December 1, 2023

概括

采用细胞免疫疗法 (ACT) 通过注入活性免疫细胞提供有前途的癌症治疗方法. 虽然化学抗原受体 (CAR) -T细胞在血液癌症中表现出成功,但瘤透淋巴细胞 (TIL) 疗法对固体瘤有效,目前正在研究其他ACT类型.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

采用细胞免疫疗法 (ACT) 涉及注入活跃的抗瘤免疫细胞来对抗癌症.
这种疗法利用自身或异种免疫细胞来增强身体对瘤的免疫反应.

研究的目的:

审查各种采用细胞免疫疗法 (ACT) 策略的当前发展和局限性.
突出与化学抗原受体 (CAR) -T细胞和瘤透淋巴细胞 (TIL) 疗法相关的疗效和挑战.

主要方法:

审查有关不同类型的ACT现有文献.
分析CAR-T和TIL疗法的临床应用,成功和局限性.
探索新兴的ACT模式,如CAR-NK,CAR-M和TCR-T疗法.

主要成果:

化学抗原受体 (CAR) -T细胞疗法在血液恶性瘤中显示出显著的疗效,但面临着不良反应和复发的挑战.
瘤透淋巴细胞 (TIL) 疗法对固体瘤有效,其特点是T细胞受体 (TCR) 克隆性和瘤定位,尽管它的应用是瘤特异性的.
目前正在进行的研究正在通过新的方法扩大ACT的范围.

结论:

包括CAR-T和TIL疗法在内的ACT是一种强大的癌症治疗方法.
进一步的研究和开发对于克服局限性和扩大ACT对各种癌症的适用性至关重要.
新兴的ACT策略对未来的癌症免疫疗法充满希望.

关键词:

卡尔-NK 是一个卡尔-NK.在CART-T中,我们可以使用CAR-T.在CAR-巨细胞.这就是TCR-T.在TIL TIL.免疫疗法免疫疗法

更多相关视频

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...